Budtz-Jørgensen E - Search Results

1

TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).

Rostgaard N, Roos P, Budtz-Jørgensen E, Johannsen P, Waldemar G, Nørremølle A, Lindquist SG, Gydesen S, Brown JM, Collinge J, Isaacs AM; FReJA collaboration; Nielsen TT, Nielsen JE. Rostgaard N, et al. Neurobiol Aging. 2017 Nov;59:221.e1-221.e7. doi: 10.1016/j.neurobiolaging.2017.06.026. Epub 2017 Jul 11. Neurobiol Aging. 2017. PMID: 28888721

2

4p16.3 haplotype modifying age at onset of Huntington disease.

Nørremølle A, Budtz-Jørgensen E, Fenger K, Nielsen JE, Sørensen SA, Hasholt L. Nørremølle A, et al. Clin Genet. 2009 Mar;75(3):244-50. doi: 10.1111/j.1399-0004.2008.01136.x. Clin Genet. 2009. PMID: 19250382

3

NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy.

Svenstrup K, Møller RS, Christensen J, Budtz-Jørgensen E, Gilling M, Nielsen JE. Svenstrup K, et al. Eur J Neurol. 2011 Sep;18(9):1197-9. doi: 10.1111/j.1468-1331.2011.03359.x. Epub 2011 Feb 22. Eur J Neurol. 2011. PMID: 21599812

4

ATXN2 with intermediate-length CAG/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia.

Nielsen TT, Svenstrup K, Budtz-Jørgensen E, Eiberg H, Hasholt L, Nielsen JE. Nielsen TT, et al. J Neurol Sci. 2012 Oct 15;321(1-2):100-2. doi: 10.1016/j.jns.2012.07.036. Epub 2012 Aug 3. J Neurol Sci. 2012. PMID: 22868089

5

Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease.

Petersen MH, Budtz-Jørgensen E, Sørensen SA, Nielsen JE, Hjermind LE, Vinther-Jensen T, Nielsen SM, Nørremølle A. Petersen MH, et al. Mitochondrion. 2014 Jul;17:14-21. doi: 10.1016/j.mito.2014.05.001. Epub 2014 May 15. Mitochondrion. 2014. PMID: 24836434

6

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.

Vinther-Jensen T, Larsen IU, Hjermind LE, Budtz-Jørgensen E, Nielsen TT, Nørremølle A, Nielsen JE, Vogel A. Vinther-Jensen T, et al. Orphanet J Rare Dis. 2014 Jul 17;9:114. doi: 10.1186/s13023-014-0114-8. Orphanet J Rare Dis. 2014. PMID: 25026978 Free PMC article.

7

YKL-40 in cerebrospinal fluid in Huntington's disease--a role in pathology or a nonspecific response to inflammation?

Vinther-Jensen T, Budtz-Jørgensen E, Simonsen AH, Nielsen JE, Hjermind LE. Vinther-Jensen T, et al. Parkinsonism Relat Disord. 2014 Nov;20(11):1301-3. doi: 10.1016/j.parkreldis.2014.08.011. Epub 2014 Aug 28. Parkinsonism Relat Disord. 2014. PMID: 25219973 No abstract available.

8

Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.

Vinther-Jensen T, Simonsen AH, Budtz-Jørgensen E, Hjermind LE, Nielsen JE. Vinther-Jensen T, et al. Eur J Neurol. 2015 Oct;22(10):1378-84. doi: 10.1111/ene.12750. Epub 2015 Jun 13. Eur J Neurol. 2015. PMID: 26073975

9

Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes.

Vinther-Jensen T, Nielsen TT, Budtz-Jørgensen E, Larsen IU, Hansen MM, Hasholt L, Hjermind LE, Nielsen JE, Nørremølle A. Vinther-Jensen T, et al. Clin Genet. 2016 Mar;89(3):320-7. doi: 10.1111/cge.12628. Epub 2015 Jul 17. Clin Genet. 2016. PMID: 26081309

10

Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.

Vinther-Jensen T, Börnsen L, Budtz-Jørgensen E, Ammitzbøll C, Larsen IU, Hjermind LE, Sellebjerg F, Nielsen JE. Vinther-Jensen T, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e287. doi: 10.1212/NXI.0000000000000287. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27734023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters